{"entity":{"type":"insider","cik":"0001615000","url":"/insider/0001615000","json_url":"/insider/0001615000.json","name":"NORTHCOTT JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2021-02-18","last":"2022-05-17","span_basis":"filed_date"},"name_variants":[{"name":"NORTHCOTT JOHN","source":"filing","n_filings":6,"first_seen":"2021-02-18","last_seen":"2022-05-17"}],"transactions":[{"id":6429741,"accession":"0001209191-22-029900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-029900","line_url":"/filing/0001209191-22-029900#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001615000","owner_name":"NORTHCOTT JOHN","owner_display_name":"NORTHCOTT JOHN","owner_url":"/insider/0001615000","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4592.0,"shares_display":"4,592","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":18138.4,"total_display":"18,138.40","total_whole":"18,138","shares_owned_after":223210.0,"shares_owned_after_display":"223,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":6095148,"accession":"0001209191-22-011437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011437","line_url":"/filing/0001209191-22-011437#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001615000","owner_name":"NORTHCOTT JOHN","owner_display_name":"NORTHCOTT JOHN","owner_url":"/insider/0001615000","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4852.0,"shares_display":"4,852","price_per_share":10.95,"price_display":"10.95","price_state":"stated","total_value":53129.4,"total_display":"53,129.40","total_whole":"53,129","shares_owned_after":227802.0,"shares_owned_after_display":"227,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":4588301,"accession":"0001209191-21-065221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-065221","line_url":"/filing/0001209191-21-065221#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001615000","owner_name":"NORTHCOTT JOHN","owner_display_name":"NORTHCOTT JOHN","owner_url":"/insider/0001615000","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6061.0,"shares_display":"6,061","price_per_share":13.16,"price_display":"13.16","price_state":"stated","total_value":79762.76,"total_display":"79,762.76","total_whole":"79,763","shares_owned_after":194854.0,"shares_owned_after_display":"194,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-17","scope":"insider"},{"id":5047519,"accession":"0001209191-21-052385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-052385","line_url":"/filing/0001209191-21-052385#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001615000","owner_name":"NORTHCOTT JOHN","owner_display_name":"NORTHCOTT JOHN","owner_url":"/insider/0001615000","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6192.0,"shares_display":"6,192","price_per_share":13.83,"price_display":"13.83","price_state":"stated","total_value":85635.36,"total_display":"85,635.36","total_whole":"85,635","shares_owned_after":200915.0,"shares_owned_after_display":"200,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider"},{"id":5476073,"accession":"0001209191-21-034186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034186","line_url":"/filing/0001209191-21-034186#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001615000","owner_name":"NORTHCOTT JOHN","owner_display_name":"NORTHCOTT JOHN","owner_url":"/insider/0001615000","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6085.0,"shares_display":"6,085","price_per_share":18.3,"price_display":"18.30","price_state":"stated","total_value":111355.5,"total_display":"111,355.50","total_whole":"111,356","shares_owned_after":207107.0,"shares_owned_after_display":"207,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider"},{"id":4223162,"accession":"0001209191-21-012120","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-012120","line_url":"/filing/0001209191-21-012120#line-1","is_derivative":false,"issuer_cik":"0000906709","issuer_name":"NEKTAR THERAPEUTICS","issuer_ticker":"NKTR","issuer_name_source":null,"issuer_url":"/issuer/0000906709","owner_cik":"0001615000","owner_name":"NORTHCOTT JOHN","owner_display_name":"NORTHCOTT JOHN","owner_url":"/insider/0001615000","role":"Officer (SVP & Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15358.0,"shares_display":"15,358","price_per_share":22.37,"price_display":"22.37","price_state":"stated","total_value":343558.46,"total_display":"343,558.46","total_whole":"343,558","shares_owned_after":213192.0,"shares_owned_after_display":"213,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000906709","name":"NEKTAR THERAPEUTICS","url":"/issuer/0000906709","role":"Officer (SVP & Chief Commercial Officer)","n_filings":6,"first_seen":"2021-02-18","last_seen":"2022-05-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001615000","retrieved_at":"2026-08-23T00:49:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}